论文部分内容阅读
目的对经皮冠状动脉介入治疗(PCI)与溶栓用于急性ST段抬高型心肌梗死(STEMI)治疗中的临床价值进行比较。方法 54例STEMI患者,根据治疗方法不同分为观察组(行PCI)与对照组(行溶栓治疗),每组27例。对两组患者经治疗后的临床效果进行比较。结果观察组血管再通率、ST段回落情况及死亡率优于对照组,差异有统计学意义(P<0.05)。结论 PCI作为一种再通率较高、安全性较高的治疗方法 ,可作为STEMI治疗的首选方案,在临床进行广泛推广。
Objective To compare the clinical value of percutaneous coronary intervention (PCI) with thrombolysis in the treatment of acute ST-segment elevation myocardial infarction (STEMI). Methods 54 STEMI patients were divided into observation group (PCI) and control group (thrombolytic therapy) according to different treatment methods, with 27 cases in each group. The clinical effects of the two groups after treatment were compared. Results The vascular recanalization rate, ST segment regression and mortality in the observation group were better than those in the control group (P <0.05). Conclusion PCI as a high recanalization rate and high security treatment can be used as the first choice of STEMI treatment in the clinical widely.